> top > docs > PMC:7253482 > spans > 137-402 > annotations

PMC:7253482 / 137-402 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
26 51-55 Species denotes CoVs Tax:11118
27 254-265 Species denotes Coronavirus Tax:11118
33 230-235 Gene denotes spike Gene:43740568
41 61-69 Disease denotes zoonotic MESH:D015047

LitCovid-PD-FMA-UBERON

Id Subject Object Predicate Lexical cue fma_id
T1 240-252 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 149-156 http://purl.obolibrary.org/obo/CLO_0009985 denotes focuses

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 240-252 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089

LitCovid-sample-PD-IDO

Id Subject Object Predicate Lexical cue
T1 70-79 http://purl.obolibrary.org/obo/IDO_0000528 denotes pathogens
T2 201-224 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 209-224 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T18 3-7 NNP denotes East
T19 8-19 JJ denotes respiratory
T20 20-28 NN denotes syndrome
T21 29-30 -LRB- denotes (
T22 30-34 NNS denotes MERS
T23 34-35 -RRB- denotes )
T24 36-49 NNS denotes coronaviruses
T25 50-51 -LRB- denotes (
T26 51-55 NNS denotes CoVs
T27 55-56 -RRB- denotes )
T28 57-60 VBP denotes are
T29 61-69 JJ denotes zoonotic
T30 70-79 NNS denotes pathogens
T31 80-84 IN denotes with
T32 85-89 JJ denotes high
T33 90-98 NN denotes fatality
T34 99-104 NNS denotes rates
T35 105-108 CC denotes and
T36 109-117 JJ denotes pandemic
T37 118-127 NN denotes potential
T38 129-136 NN denotes Vaccine
T39 137-148 NN denotes development
T40 149-156 VBZ denotes focuses
T41 157-159 IN denotes on
T42 160-163 DT denotes the
T43 164-173 JJ denotes principal
T44 174-180 NN denotes target
T45 181-183 IN denotes of
T46 184-187 DT denotes the
T47 188-200 VBG denotes neutralizing
T48 201-208 JJ denotes humoral
T49 209-215 JJ denotes immune
T50 216-224 NN denotes response
T51 224-225 -COMMA- denotes ,
T52 226-229 DT denotes the
T53 230-235 NN denotes spike
T54 236-237 -LRB- denotes (
T55 237-238 NN denotes S
T56 238-239 -RRB- denotes )
T57 240-252 NN denotes glycoprotein
T58 254-265 NN denotes Coronavirus
R16 T20 T18 arg1Of syndrome,East
R17 T20 T19 arg1Of syndrome,respiratory
R18 T20 T21 arg1Of syndrome,(
R19 T22 T21 arg2Of MERS,(
R20 T23 T21 arg3Of ),(
R21 T28 T24 arg1Of are,coronaviruses
R22 T24 T25 arg1Of coronaviruses,(
R23 T26 T25 arg2Of CoVs,(
R24 T27 T25 arg3Of ),(
R26 T30 T28 arg2Of pathogens,are
R27 T30 T29 arg1Of pathogens,zoonotic
R28 T30 T31 arg1Of pathogens,with
R29 T35 T31 arg2Of and,with
R30 T34 T32 arg1Of rates,high
R31 T34 T33 arg1Of rates,fatality
R32 T34 T35 arg1Of rates,and
R33 T37 T35 arg2Of potential,and
R34 T37 T36 arg1Of potential,pandemic
R35 T39 T38 arg1Of development,Vaccine
R36 T39 T40 arg1Of development,focuses
R37 T40 T41 arg1Of focuses,on
R38 T44 T41 arg2Of target,on
R39 T44 T42 arg1Of target,the
R40 T44 T43 arg1Of target,principal
R41 T44 T45 arg1Of target,of
R42 T50 T45 arg2Of response,of
R43 T50 T46 arg1Of response,the
R44 T50 T47 arg1Of response,neutralizing
R45 T50 T48 arg1Of response,humoral
R46 T50 T49 arg1Of response,immune
R47 T50 T51 arg1Of response,","
R48 T57 T51 arg2Of glycoprotein,","
R49 T57 T52 arg1Of glycoprotein,the
R50 T57 T53 arg1Of glycoprotein,spike
R51 T53 T54 arg1Of spike,(
R52 T55 T54 arg2Of S,(
R53 T56 T54 arg3Of ),(

LitCovid-sample-PD-FMA

Id Subject Object Predicate Lexical cue fma_id
T1 240-252 Body_part denotes glycoprotein http://purl.org/sig/ont/fma/fma62925

LitCovid-sample-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T1 240-252 Chemical denotes glycoprotein http://purl.obolibrary.org/obo/CHEBI_17089

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T3 30-34 Species denotes MERS NCBItxid:1335626

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T4 129-253 Sentence denotes Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotein.

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
68 36-49 Species denotes coronaviruses Tax:11118
69 51-55 Species denotes CoVs Tax:11118
26 51-55 Species denotes CoVs Tax:11118
41 61-69 Disease denotes zoonotic MESH:D015047
33 230-235 Gene denotes spike Gene:43740568
27 254-265 Species denotes Coronavirus Tax:11118

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T1 236-252 Protein denotes (S) glycoprotein https://www.uniprot.org/uniprot/Q9QAS2|https://www.uniprot.org/uniprot/Q9QAR5|https://www.uniprot.org/uniprot/Q9QAQ8|https://www.uniprot.org/uniprot/Q9IW04|https://www.uniprot.org/uniprot/Q9IKD1|https://www.uniprot.org/uniprot/Q990M4|https://www.uniprot.org/uniprot/Q990M3|https://www.uniprot.org/uniprot/Q990M2|https://www.uniprot.org/uniprot/Q990M1|https://www.uniprot.org/uniprot/Q91AV1|https://www.uniprot.org/uniprot/Q91A26|https://www.uniprot.org/uniprot/Q8V436|https://www.uniprot.org/uniprot/Q8JSP8|https://www.uniprot.org/uniprot/Q8BB25|https://www.uniprot.org/uniprot/Q86623|https://www.uniprot.org/uniprot/Q85088|https://www.uniprot.org/uniprot/Q85087|https://www.uniprot.org/uniprot/Q80BV6|https://www.uniprot.org/uniprot/Q7TFB1|https://www.uniprot.org/uniprot/Q7TFA2|https://www.uniprot.org/uniprot/Q7TA19|https://www.uniprot.org/uniprot/Q7T6T3|https://www.uniprot.org/uniprot/Q7T696|https://www.uniprot.org/uniprot/Q77NC4|https://www.uniprot.org/uniprot/Q6TNF9|https://www.uniprot.org/uniprot/Q6R1L7|https://www.uniprot.org/uniprot/Q6QU82|https://www.uniprot.org/uniprot/Q6Q1S2|https://www.uniprot.org/uniprot/Q696Q6|https://www.uniprot.org/uniprot/Q66291|https://www.uniprot.org/uniprot/Q66290|https://www.uniprot.org/uniprot/Q66199|https://www.uniprot.org/uniprot/Q66177|https://www.uniprot.org/uniprot/Q66176|https://www.uniprot.org/uniprot/Q66174|https://www.uniprot.org/uniprot/Q65984|https://www.uniprot.org/uniprot/Q5MQD0|https://www.uniprot.org/uniprot/Q5I5X9|https://www.uniprot.org/uniprot/Q5DIY0|https://www.uniprot.org/uniprot/Q5DIX9|https://www.uniprot.org/uniprot/Q5DIX8|https://www.uniprot.org/uniprot/Q5DIX7|https://www.uniprot.org/uniprot/Q52PA3|https://www.uniprot.org/uniprot/Q4U5G0|https://www.uniprot.org/uniprot/Q3T8J0|https://www.uniprot.org/uniprot/Q3LZX1|https://www.uniprot.org/uniprot/Q3I5J5|https://www.uniprot.org/uniprot/Q14EB0|https://www.uniprot.org/uniprot/Q0ZME7|https://www.uniprot.org/uniprot/Q0Q4F2|https://www.uniprot.org/uniprot/Q0Q475|https://www.uniprot.org/uniprot/Q0Q466|https://www.uniprot.org/uniprot/Q0GNB8|https://www.uniprot.org/uniprot/Q02385|https://www.uniprot.org/uniprot/Q02167|https://www.uniprot.org/uniprot/Q01977|https://www.uniprot.org/uniprot/Q008X4|https://www.uniprot.org/uniprot/P89344|https://www.uniprot.org/uniprot/P89343|https://www.uniprot.org/uniprot/P89342|https://www.uniprot.org/uniprot/P59594|https://www.uniprot.org/uniprot/P36334|https://www.uniprot.org/uniprot/P36300|https://www.uniprot.org/uniprot/P33470|https://www.uniprot.org/uniprot/P30208|https://www.uniprot.org/uniprot/P30207|https://www.uniprot.org/uniprot/P30206|https://www.uniprot.org/uniprot/P30019|https://www.uniprot.org/uniprot/P27655|https://www.uniprot.org/uniprot/P25194|https://www.uniprot.org/uniprot/P25193|https://www.uniprot.org/uniprot/P25192|https://www.uniprot.org/uniprot/P25191|https://www.uniprot.org/uniprot/P25190|https://www.uniprot.org/uniprot/P24413|https://www.uniprot.org/uniprot/P23052|https://www.uniprot.org/uniprot/P22432|https://www.uniprot.org/uniprot/P18450|https://www.uniprot.org/uniprot/P17662|https://www.uniprot.org/uniprot/P15777|https://www.uniprot.org/uniprot/P15423|https://www.uniprot.org/uniprot/P12722|https://www.uniprot.org/uniprot/P12651|https://www.uniprot.org/uniprot/P12650|https://www.uniprot.org/uniprot/P11225|https://www.uniprot.org/uniprot/P11224|https://www.uniprot.org/uniprot/P11223|https://www.uniprot.org/uniprot/P10033|https://www.uniprot.org/uniprot/P0DTC2|https://www.uniprot.org/uniprot/P07946|https://www.uniprot.org/uniprot/P05135|https://www.uniprot.org/uniprot/P05134|https://www.uniprot.org/uniprot/O90304|https://www.uniprot.org/uniprot/O39227|https://www.uniprot.org/uniprot/K9N5Q8|https://www.uniprot.org/uniprot/A3EXG6|https://www.uniprot.org/uniprot/A3EXD0|https://www.uniprot.org/uniprot/A3EX94|https://www.uniprot.org/uniprot/Q4ZJS1

LitCovid-sample-PD-GO-BP-0

Id Subject Object Predicate Lexical cue
T2 201-224 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 209-224 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-sample-GO-BP

Id Subject Object Predicate Lexical cue
T2 201-224 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 209-224 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-PD-GO-BP

Id Subject Object Predicate Lexical cue
T2 201-224 http://purl.obolibrary.org/obo/GO_0006959 denotes humoral immune response
T3 209-224 http://purl.obolibrary.org/obo/GO_0006955 denotes immune response

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T4 129-253 Sentence denotes Vaccine development focuses on the principal target of the neutralizing humoral immune response, the spike (S) glycoprotein.